EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Screening and epitope characterization of Nidogen‐2‐specific nanobodies

Jianchuan Wen iD, Qianqian Cui, Zhongyun Lan, Yingjun Wang, Shuaiying Zhao, Wenxuan Feng, Yunfeng Liu, Qiting Huang, Dongna Zhang, Jianfeng Xu

FEBS Open Bio · 2026-08 · 16 (8) · 1459-1476

DOI: 10.1002/2211-5463.70219 ↗

Kurz gefasst

Fachartikel in der Zeitschrift FEBS Open Bio, online erschienen am 04.03.2026. Verfasst von Jianchuan Wen und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Food Science and Technology, Shanghai Ocean University, China. Hauptthemen laut MEDLINE: Single-Domain Antibodies, Epitopes, Cell Adhesion Molecules. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

NID2 is a key component of the BM and plays an important role in ECM organization and tumor‐associated microenvironmental remodeling. In this study, full‐length recombinant NID2 was used as an antigen to immunize camels, and a nanobody phage display library was constructed from peripheral blood lymphocytes. Using phage display‐based screening, nanobodies recognizing distinct epitopes within the NID2 G1G2 and rod–G3 domains were isolated and characterized. Epitope specificity and competition were further analyzed by BLI, allowing the identification of nonoverlapping nanobody pairs. Based on these results, two high‐affinity nanobodies were selected to establish a nanobody‐based sandwich ELISA for NID2 detection. This assay enabled the detection of recombinant NID2 at concentrations down to 10 ng·mL −1 in human serum. Although the analytical sensitivity is lower than that of some commercial antibody‐based ELISA kits, the nanobody‐based format offers advantages in terms of recombinant production, scalability, and assay design flexibility. Collectively, this study provides a panel of domain‐selective nanobodies against NID2 and establishes a nanobody‐based sandwich ELISA as a methodological platform for future investigations of serum NID2 in diagnostic and translational research contexts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Single-Domain AntibodiesEpitopesCell Adhesion MoleculesAnimalsHumansEnzyme-Linked Immunosorbent AssayRecombinant ProteinsCamelusPeptide LibraryCalcium-Binding Proteins

Stichwörter der Autor:innen

Nidogen‐2 (NID2)Sandwich ELISAnanobodyphage display

Substanzen

Single-Domain AntibodiesEpitopesCell Adhesion MoleculesRecombinant ProteinsNID2 protein, humanPeptide LibraryCalcium-Binding Proteins

Autor:innen und Institutionen

  • College of Food Science and Technology, Shanghai Ocean University, China.
  • Shanghai Institute of Materia Medica, Chinese Academy of Sciences, China.
  • School of Pharmacy, Nanjing University of Chinese Medicine, China.

ORCID-Profile: Jianchuan Wen

Zitieren

APA

Wen, J., Cui, Q., Lan, Z., Wang, Y., Zhao, S., Feng, W., Liu, Y., Huang, Q., Zhang, D., & Xu, J. (2026). Screening and epitope characterization of Nidogen‐2‐specific nanobodies. FEBS Open Bio, 16(8), 1459-1476. https://doi.org/10.1002/2211-5463.70219

Vancouver

Wen J, Cui Q, Lan Z, Wang Y, Zhao S, Feng W, et al. Screening and epitope characterization of Nidogen‐2‐specific nanobodies. FEBS Open Bio. 2026;16(8):1459-1476. doi:10.1002/2211-5463.70219

BibTeX
@article{Wen2026,
  author = {Wen, Jianchuan and Cui, Qianqian and Lan, Zhongyun and Wang, Yingjun and Zhao, Shuaiying and Feng, Wenxuan and Liu, Yunfeng and Huang, Qiting and Zhang, Dongna and Xu, Jianfeng},
  title = {Screening and epitope characterization of Nidogen‐2‐specific nanobodies},
  journal = {FEBS Open Bio},
  year = {2026},
  volume = {16},
  number = {8},
  pages = {1459--1476},
  doi = {10.1002/2211-5463.70219}
}
Kostenlos starten →